RUA Life Sciences (LON:RUA) Trading Up 5.9% – Here’s Why

RUA Life Sciences plc (LON:RUAGet Free Report) was up 5.9% during mid-day trading on Tuesday . The company traded as high as GBX 21.92 and last traded at GBX 20.65. Approximately 193,484 shares changed hands during mid-day trading, a decline of 19% from the average session volume of 237,918 shares. The stock had previously closed at GBX 19.50.

RUA Life Sciences Price Performance

The company has a quick ratio of 7.32, a current ratio of 4.64 and a debt-to-equity ratio of 18.95. The company’s fifty day moving average price is GBX 20.03 and its 200 day moving average price is GBX 16.11. The company has a market capitalization of £12.82 million, a P/E ratio of -2.61 and a beta of 0.95.

RUA Life Sciences (LON:RUAGet Free Report) last issued its quarterly earnings results on Tuesday, June 30th. The company reported GBX (0.33) earnings per share (EPS) for the quarter. RUA Life Sciences had a negative return on equity of 2.03% and a negative net margin of 3.26%.

RUA Life Sciences Company Profile

(Get Free Report)

The RUA Life Sciences group was created in April 2020 when AorTech International plc acquired RUA Medical Devices Ltd to create a fully formed medical device business. RUA Life Sciences is the holding company of the group trading through four businesses all exploiting the group’s polymer technology. Our vision is to improve the lives of millions of patients by improving and enabling medical devices with Elast-EonTM, the worlds leading long term implantable polyurethane.

Featured Stories

Receive News & Ratings for RUA Life Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RUA Life Sciences and related companies with MarketBeat.com's FREE daily email newsletter.